Skip to main content
. 2018 Aug 16;2(2):rky026. doi: 10.1093/rap/rky026

Table 3.

Pharmacologic and vascular treatments administered during the follow-up period

Treatments Unilateral RAI (n = 18) Bilateral RAI (n = 19)
Systemic treatments, n (%)
 GC alone 0 (0) 4 (21)
 ISD ± GC 15 (83) 14 (73)
 None 3 (16) 1 (5)
Number of antihypertensives, median (IQR) 1 (0–1.75) 1 (0.5–3)
Vascular treatments, n (%)
 Endovascular 2 (11) 3 (16)
 Surgical 1 (6) 2 (11)